ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TRXC TransEnterix Inc New

4.08
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
TransEnterix Inc New AMEX:TRXC AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.08 0 01:00:00

TransEnterix Schedules Second Quarter Financial and Operating Results Conference Call for August 5, 2020

22/07/2020 11:55am

Business Wire


TransEnterix (AMEX:TRXC)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more TransEnterix Charts.

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release second quarter financial and operating results after the market closes on Wednesday, August 5, 2020. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast.

To listen to the conference call on your telephone, please dial 1-855-327-6837 for domestic callers and 1-631-891-4304 for international callers, and reference conference ID 10010432 approximately ten minutes prior to the start time. To access the live audio webcast or archived recording, use the following link http://ir.transenterix.com/events.cfm. The replay will be available on the Company’s website.

About TransEnterix

TransEnterix is a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today's value-based healthcare environment. The Company is focused on the market development activities for, and increasing utilization of, its Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery. The system allows for robotic precision, haptic feedback, surgeon camera control via eye sensing and improved ergonomics while offering responsible economics. The Senhance Surgical System is available for sale in the US, the EU, Japan and select other countries. For more information, visit www.transenterix.com.

TransEnterix, Inc. Investors: Mark Klausner, 443-213-0501 invest@transenterix.com or Media: Terri Clevenger, 203-856-8297 terri.clevenger@icrinc.com

1 Year TransEnterix Chart

1 Year TransEnterix Chart

1 Month TransEnterix Chart

1 Month TransEnterix Chart

Your Recent History

Delayed Upgrade Clock